203 related articles for article (PubMed ID: 23671131)
21. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
[TBL] [Abstract][Full Text] [Related]
22. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
24. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
[TBL] [Abstract][Full Text] [Related]
25. Integrated bioinformatics analysis revealed the regulation of angiogenesis by tumor cells in hepatocellular carcinoma.
Huo M; Yu K; Zheng Y; Liu L; Zhao H; Li X; Huang C; Zhang J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34151937
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
Zhang T; Sun HC; Xu Y; Zhang KZ; Wang L; Qin LX; Wu WZ; Liu YK; Ye SL; Tang ZY
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8557-63. PubMed ID: 16361537
[TBL] [Abstract][Full Text] [Related]
27. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
Tan S; Li R; Ding K; Lobie PE; Zhu T
FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389
[TBL] [Abstract][Full Text] [Related]
28. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
Xu T; Zhu Y; Wei QK; Yuan Y; Zhou F; Ge YY; Yang JR; Su H; Zhuang SM
Carcinogenesis; 2008 Nov; 29(11):2126-31. PubMed ID: 18711148
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression.
Fang JH; Zhou HC; Zeng C; Yang J; Liu Y; Huang X; Zhang JP; Guan XY; Zhuang SM
Hepatology; 2011 Nov; 54(5):1729-40. PubMed ID: 21793034
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma.
Yang Y; Zhang J; Xia T; Li G; Tian T; Wang M; Wang R; Zhao L; Yang Y; Lan K; Zhou W
Oncol Rep; 2016 Nov; 36(5):2553-2562. PubMed ID: 27666683
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
[TBL] [Abstract][Full Text] [Related]
32. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
33. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
[TBL] [Abstract][Full Text] [Related]
34. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
Wong QW; Ching AK; Chan AW; Choy KW; To KF; Lai PB; Wong N
Clin Cancer Res; 2010 Feb; 16(3):867-75. PubMed ID: 20103675
[TBL] [Abstract][Full Text] [Related]
35. Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression.
Moh-Moh-Aung A; Fujisawa M; Ito S; Katayama H; Ohara T; Ota Y; Yoshimura T; Matsukawa A
Sci Rep; 2020 Jun; 10(1):10418. PubMed ID: 32591615
[TBL] [Abstract][Full Text] [Related]
36. Brain-derived neurotrophic factor promotes tumorigenesis via induction of neovascularization: implication in hepatocellular carcinoma.
Lam CT; Yang ZF; Lau CK; Tam KH; Fan ST; Poon RT
Clin Cancer Res; 2011 May; 17(10):3123-33. PubMed ID: 21421859
[TBL] [Abstract][Full Text] [Related]
37. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
[TBL] [Abstract][Full Text] [Related]
38. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.
Karakatsanis A; Papaconstantinou I; Gazouli M; Lyberopoulou A; Polymeneas G; Voros D
Mol Carcinog; 2013 Apr; 52(4):297-303. PubMed ID: 22213236
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
[TBL] [Abstract][Full Text] [Related]
40. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
